Keyword: Personalized Medicine Coalition
CMS plans to allow Medicare to cover an emerging immunotherapy for cancer patients, it announced on Friday.
The number of FDA-approved therapies for personalized medicines has jumped from 20% to 40% in the last few years.
As precision medicine continues to evolve, collaboration between the health providers at its forefront will be crucial to success.
There's plenty of work to be done in informing patients about precision medicine, according to a new survey.
Health systems that have rolled out precision medicine programs have had to tackle many challenge before seeing the efforts pay off.
President Donald Trump’s $22 million cut to the ONC in his 2018 budget left policy experts worried about ongoing health IT initiatives.
WASHINGTON, D.C.—Eric Dishman wants to expand precision medicine to the entire population of the United States.